Xarelto [SPAF] Post-marketing Surveillance in Japan
NCT01582737
·
clinicaltrials.gov ↗
COMPLETED
Status
11310
Enrollment
INDUSTRY
Sponsor class
Conditions
Brain Ischemia
Interventions
DRUG:
Rivaroxaban(Xarelto, BAY59-7939)
Sponsor
Bayer
Collaborators
[object Object]